These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 30502644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Medical cannabis use in Canadians with multiple sclerosis.
    Santarossa TM, So R, Smyth DP, Gustavsen DS, Tsuyuki DRT.
    Mult Scler Relat Disord; 2022 Mar; 59():103638. PubMed ID: 35382939
    [Abstract] [Full Text] [Related]

  • 7. Characterizing cannabis use in a sample of adults with multiple sclerosis and chronic pain: An observational study.
    Link K, Knowles LM, Alschuler KN, Ehde DM.
    Mult Scler Relat Disord; 2023 Jul; 75():104742. PubMed ID: 37156034
    [Abstract] [Full Text] [Related]

  • 8. Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis.
    Guarnaccia JB, Khan A, Ayettey R, Treu JA, Comerford B, Njike VY.
    Mult Scler Relat Disord; 2021 May; 50():102830. PubMed ID: 33636612
    [Abstract] [Full Text] [Related]

  • 9. Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.
    Kindred JH, Li K, Ketelhut NB, Proessl F, Fling BW, Honce JM, Shaffer WR, Rudroff T.
    Complement Ther Med; 2017 Aug; 33():99-104. PubMed ID: 28735833
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L, Minozzi S, Mitrova Z, Parmelli E, Saulle R, Cruciani F, Vecchi S, Davoli M.
    Epidemiol Prev; 2017 Aug; 41(5-6):279-293. PubMed ID: 29119763
    [Abstract] [Full Text] [Related]

  • 12. Cannabis and multiple sclerosis.
    Fragoso YD, Carra A, Macias MA.
    Expert Rev Neurother; 2020 Aug; 20(8):849-854. PubMed ID: 32515670
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards.
    Maayah ZH, Dyck JRB.
    Inflamm Res; 2020 Nov; 69(11):1073-1076. PubMed ID: 32860528
    [Abstract] [Full Text] [Related]

  • 17. Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis.
    Rice J, Hugos C, Hildebrand A, Cameron M.
    Mult Scler Relat Disord; 2020 Jun; 41():102009. PubMed ID: 32086163
    [Abstract] [Full Text] [Related]

  • 18. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O, Feinstein A.
    Neurology; 2008 Jul 15; 71(3):164-9. PubMed ID: 18272863
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cannabinoids and bladder symptoms in multiple sclerosis.
    Kim-Fine S, Greenfield J, Chaput KH, Robert M, Metz LM.
    Mult Scler Relat Disord; 2021 Sep 15; 54():103105. PubMed ID: 34216995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.